Service de radio-oncologie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


974 publications

... | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ...
2016
Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991.
Bolla M., Maingon P., Carrie C., Villa S., Kitsios P., Poortmans P.M., Sundar S., van der Steen-Banasik E.M., Armstrong J., Bosset J.F. et al., 2016/05/20. Journal of clinical oncology, 34 (15) pp. 1748-1756. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_90CAFB1C78DC]
Optimization of re-irradiation using deformable registration: a case study
Jumeau Raphaël, Péguret Nicolas, Zulliger Cédric, Moeckli Raphaël, Bourhis Jean, Ozsahin Esat-Mahmut, 2016/05. BJR|case reports, 2 (2) p. 20150412. Peer-reviewed.
[URN][DOI][serval:BIB_35DB427264AD]
 
Focal radiotherapy for multiple brain metastases
Schiappacasse Luis, 2016/04/29. p. 282 dans ESTRO 35, Radiotherapy & Oncology.
[serval:BIB_AEA555D200AD]
 
Prise en charge des tumeurs cérébrales primaires: une approche multidisciplinaire [Multidisciplinar approach to the management of gliomas]
Moura B., Migliorini D., Bourhis J., Daniel R., Levivier M., Hottinger A.F., 2016/04/27. Revue medicale suisse, 12 (516) pp. 821-825.
[Pmid][serval:BIB_195E897B3E1C]
 
PO-0793: The Advanced Markus ionization chamber is useable for measurements at ultra high dose rates
Petersson K., Jaccard M., Buchillier T., Bailat C., Germond J., Vozenin M., Bourhis J., Bochud F., 2016/04. Radiotherapy and Oncology, 119 pp. S373.
[DOI][serval:BIB_B3A25E9C1209]
[(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
Herrera F.G., Breuneval T., Prior J.O., Bourhis J., Ozsahin M., 2016/03/16. Radiation oncology, 11 p. 43. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7EB4C9B21B02]
Reduction of Respiratory Motion During PET/CT by Pulsatile-Flow Ventilation: A First Clinical Evaluation.
Prior J.O., Péguret N., Pomoni A., Pappon M., Zeverino M., Belmondo B., Lovis A., Ozsahin M., Vienne M., Bourhis J., 2016/03. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 57 (3) pp. 416-419. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DA38095A6DCE]
 
"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer?
Arcangeli S., Zilli T., De Bari B., Alongi F., 2016. Critical Reviews In Oncology/hematology, 97 pp. 231-237. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3021B314D44B]
 
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective.
Arcangeli S., Ramella S., De Bari B., Franco P., Alongi F., D'Angelillo R.M., 2016. Critical Reviews In Oncology/hematology, 97 pp. 322-327. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_23D2DD8EAC27]
 
Antifibrotic, Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl-Induced Systemic Sclerosis.
Maria A.T., Toupet K., Bony C., Pirot N., Vozenin M.C., Petit B., Roger P., Batteux F., Le Quellec A., Jorgensen C. et al., 2016. Arthritis and Rheumatology (hoboken, N.j.), 68 (4) pp. 1013-1025. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D66FAC309341]
 
Apnea-like suppression of respiratory motion: First evaluation in radiotherapy.
Péguret N., Ozsahin M., Zeverino M., Belmondo B., Durham A.D., Lovis A., Simons J., Long O., Duclos F., Prior J. et al., 2016. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology, 118 (2) pp. 220-226. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_721A2FE5C894]
 
Can Stereotactic Body Radiotherapy Really Be Considered the Preferred Treatment in Large Hepatocellular Carcinoma?
De Bari B., Ozsahin M., Bize P., Boussaha T., Deplanque G., Wagner D., Bourhis J., Denys A., 2016. Journal of Clinical Oncology, 34 (23) pp. 2798-2799. Peer-reviewed.
[DOI][Pmid][serval:BIB_3348C7FA293C]
Comparison between Stromal Vascular Fraction and Adipose Mesenchymal Stem Cells in Remodeling Hypertrophic Scars.
Domergue S., Bony C., Maumus M., Toupet K., Frouin E., Rigau V., Vozenin M.C., Magalon G., Jorgensen C., Noël D., 2016. PloS one, 11 (5) pp. e0156161. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CE5C365DB6C3]
 
Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial?.
Bourgier C., Kerns S., Gourgou S., Lemanski C., Gutowski M., Fenoglietto P., Romieu G., Crompton N., Lacombe J., Pèlegrin A. et al., 2016. Annals of Oncology, 27 (3) pp. 474-480. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7D4F948355EB]
 
ESTRO-ACROP guideline "target delineation of glioblastomas".
Niyazi M., Brada M., Chalmers A.J., Combs S.E., Erridge S.C., Fiorentino A., Grosu A.L., Lagerwaard F.J., Minniti G., Mirimanoff R.O. et al., 2016. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology, 118 (1) pp. 35-42. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_23BB2A114835]
 
Impact of respiratory-correlated CT sorting algorithms on the choice of margin definition for free-breathing lung radiotherapy treatments.
Thengumpallil S., Germond J.F., Bourhis J., Bochud F., Moeckli R., 2016. Radiotherapy and Oncology, 119 (3) pp. 438-443. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BC29DC8704FC]
 
Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity.
COPERNIC project investigators, Granzotto A., Granzotto A., Benadjaoud M.A., Vogin G., Devic C., Ferlazzo M.L., Bodgi L., Pereira S., Sonzogni L. et al., 2016. International Journal of Radiation Oncology, Biology, Physics, 94 (3) pp. 450-460. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_275D608E4036]
 
Jaw Immobilization for Gamma Knife Surgery in Patients with Mandibular Lesions: A Newly, Innovative Approach.
Tuleasca C., Broome M., Mosimann P.J., Schiappacasse L., Zeverino M., Dorenlot A., Champoudry J., Régis J., Levivier M., 2016. Stereotactic and functional neurosurgery, 94 (5) pp. 342-347. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5DE981C6EA2F]
Outcomes of preoperative chemoradiotherapy followed by surgery in patients with unresectable locally advanced sigmoid colon cancer.
Qiu B., Ding P.R., Cai L., Xiao W.W., Zeng Z.F., Chen G., Lu Z.H., Li L.R., Wu X.J., Mirimanoff R.O. et al., 2016. Chinese journal of cancer, 35 (1) p. 65. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_18BCB16AF802]
Primary Hepatic Lymphoma: A Retrospective, Multicenter Rare Cancer Network Study.
Ugurluer G., Miller R.C., Li Y., Thariat J., Ghadjar P., Schick U., Ozsahin M., 2016. Rare Tumors, 8 (3) p. 6502. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1CF652058495]
 
PrP(c) deficiency and dasatinib protect mouse intestines against radiation injury by inhibiting of c-Src.
Strup-Perrot C., Vozenin M.C., Monceau V., Pouzoulet F., Petit B., Holler V., Perrot S., Desquibert L., Fouquet S., Souquere S. et al., 2016. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology, 120 (1) pp. 175-183. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1646BF5BEE4F]
Radiation Therapy after Radical Prostatectomy: Implications for Clinicians.
Herrera F.G., Berthold D.R., 2016. Frontiers In Oncology, 6 p. 117. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B2C625B19773]
 
Reply to N.F. Saba and S.J. Wong.
Harrington K.J., Bourhis J., 2016. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 34 (17) pp. 2073-2074. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BE3E7341AF5A]
 
Spinal metastases: Is stereotactic body radiation therapy supported by evidences?
De Bari B., Alongi F., Mortellaro G., Mazzola R., Schiappacasse L., Guckenberger M., 2016. Critical Reviews In Oncology/hematology, 98 pp. 147-158. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_94AAF27D1F1B]
 
The Pocketable Electronic Devices in Radiation Oncology (PEDRO) Project: How the Use of Tools in Medical Decision Making is Changing?
De Bari B., Franco P., Niyazi M., Cornetto A.P., Qvortrup C., Martin A.N., Cacicedo J., Fernandez G., Louro L.V., Lestrade L. et al., 2016. Technology In Cancer Research and Treatment, 15 (2) pp. 365-376. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B93EAFE39DB8]
2015
 
A metastatic relapse associated with hippocampal dose sparing after whole-brain radiotherapy.
Cosinschi A., Coskun M., Negretti L., Matzinger O., Jeanneret-Sozzi W., Vallet V., Moeckli R., Mirimanoff R.O., Schiappacasse L., Ozsahin M. et al., 2015/11. Acta oncologica, 54 (10) pp. 1824-1826. Peer-reviewed.
[DOI][Pmid][serval:BIB_D3DC25934B6C]
 
Treatment deintensification and symptom burden in patients with human papillomavirus-associated head and neck cancer.
Ozsahin M., Bourhis J., 2015/11. Cancer, 121 (7) pp. 1147-1148. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8E492303C543]
 
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study.
Guigay J., Fayette J., Dillies A.F., Sire C., Kerger J.N., Tennevet I., Machiels J.P., Zanetta S., Pointreau Y., Bozec Le Moal L. et al., 2015/09. Annals of oncology : official journal of the European Society for Medical Oncology, 26 (9) pp. 1941-1947.
[DOI][Pmid][serval:BIB_29534AACA585]
 
Combined approach for the management of large vestibular schwannomas : planned subtotal resection followed by gamma knife surgery in a series of 25 consecutive cases
Daniel R.T., Tuleasca C., George M., Schiappacasse L., Zeverino M., Maire R., Levivier M., 2015/06. p. 141 dans 12-th International Stereotactic Radiosurgery Society Congress (ISRS), Journal of Radiosurgery and SBRT.
[serval:BIB_4A0B6EF88F9F]
 
Gamma Knife surgery versus Linac for brain metastases : which technique for which patient? Analysis of an historical cohort of 63 consecutive patients harbouring 130 lesions
Levivier M., Tuleasca C., Schiappacasse L., Gevaert T., Faouzi M., von Elm E., Steenbecke F., Engels B., de Ridder M., Bourhis J., 2015/06., 12-th International Stereotactic Radiosurgery Society Congress (ISRS), June 2015, Yokohama, Japan p. 42 dans Journal of Radiosurgery and SBRT.
[serval:BIB_EF45A1B96711]
 
Stereotactic body radiotherapy with helical TomoTherapy for medically inoperable early stage primary and second-primary non-small-cell lung neoplasm: 1-year outcome and toxicity analysis.
Casutt A., Bouchaab H., Beigelman-Aubry C., Bourhis J., Lovis A., Matzinger O., 2015/05. British Journal of Radiology, 88 (1049) p. 20140687. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6BCC7D2FB16E]
 
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies.
De Bari B., Filippi A.R., Mazzola R., Bonomo P., Trovò M., Livi L., Alongi F., 2015. Cancer Treatment Reviews, 41 (6) pp. 511-518. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_06F13E4E3F89]
 
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.
Blanchard P., Lee A., Marguet S., Leclercq J., Ng W.T., Ma J., Chan A.T., Huang P.Y., Benhamou E., Zhu G. et al., 2015. Lancet. Oncology, 16 (6) pp. 645-655. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_920EFC84A8D1]
 
Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era.
D'Angelillo R.M., Franco P., De Bari B., Fiorentino A., Arcangeli S., Alongi F., 2015. Critical Reviews in Oncology/hematology, 93 (2) pp. 136-148. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C6A109D5D67B]
 
Could concomitant radio-chemotherapy improve the outcomes of early-stage node negative anal canal cancer patients? A retrospective analysis of 122 patients.
De Bari B., Lestrade L., Pommier P., Maddalo M., Buglione M., Magrini S.M., Carrie C., 2015. Cancer Investigation, 33 (4) pp. 114-120. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_498D80BD8F46]
 
Could machine learning improve the prediction of pelvic nodal status of prostate cancer patients? Preliminary results of a pilot study.
De Bari B., Vallati M., Gatta R., Simeone C., Girelli G., Ricardi U., Meattini I., Gabriele P., Bellavita R., Krengli M. et al., 2015. Cancer Investigation, 33 (6) pp. 232-240. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D2C8C19D0F93]
 
CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines.
Brouwer C.L., Steenbakkers R.J., Bourhis J., Budach W., Grau C., Grégoire V., van Herk M., Lee A., Maingon P., Nutting C. et al., 2015. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology, 117 (1) pp. 83-90. Peer-reviewed.
[DOI][Pmid][serval:BIB_3820E4581114]
 
Gamma Knife Surgery versus Linac for Brain Metastasis: Which Technique for Which Patient? Analysis of an Historical Cohort of 63 Consecutive Patients Harboring 130 Lesions
Levivier M., Tuleasca C., Schiappacasse L., Gevaert T., Faouzi M., Von Elm E., Steenbecke F., Engels B., de Ridder M., Bourhis J., 2015., Joint Annual Meeting 2015: Swiss Society of Neurosurgery and Swiss Society of Neuroradiology Together with IG-NOPPS, Lucerne, Switzerland, 10-11 September 2015 pp. 1-2 dans journal of Neurological Surgery Part A: Central European Neurosurgery.
[DOI][serval:BIB_C7DD8550D443]
Gemeinsamkeiten und Unterschiede der primären Radiotherapie beim lokalisierten und lokal fortgeschrittenen Prostatakarzinom in der Schweiz : Eine Analyse der der Behandlungskonzepte Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland : A survey on patterns of practice.
Panje C.M., Dal Pra A., Zilli T., R Zwahlen D., Papachristofilou A., Herrera F.G., Matzinger O., Plasswilm L., Putora P.M., 2015. Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [et Al], 191 (10) pp. 778-786. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_90BE0A0F0301]
 
Helical tomotherapy for the treatment of anal canal cancer: a dosimetric comparison with 3D conformal radiotherapy.
Ugurluer G., Ballerini G., Moeckli R., Matzinger O., Bourhis J., Ozsahin M., 2015. Tumori, 101 (3) pp. 268-272. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_77681F450B35]
 
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.
Pless M., Stupp R., Ris H.B., Stahel R.A., Weder W., Thierstein S., Gerard M.A., Xyrafas A., Früh M., Cathomas R. et al., 2015. Lancet, 386 (9998) pp. 1049-1056. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6A9C926D89F3]
 
Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature.
De Bari B., Daidone A., Alongi F., 2015. Critical Reviews in Oncology/hematology, 94 (3) pp. 360-370. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C0171FEF9037]
 
La radiothérapie FLASH pour épargner les tissus sains [The radiotherapy FLASH to save healthy tissues].
Favaudon V., Fouillade C., Vozenin M.C., 2015. Médecine Sciences : M/s, 31 (2) pp. 121-123. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E42B1E19A696]
 
Late side-effects after curative intent radiotherapy: Identification of hypersensitive patients for personalized strategy.
Bourgier C., Lacombe J., Solassol J., Mange A., Pèlegrin A., Ozsahin M., Azria D., 2015. Critical Reviews in Oncology/hematology, 93 (3) pp. 312-319. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D613E45778BB]
 
Multidisciplinary approach of lumbo-sacral chordoma: From oncological treatment to reconstructive surgery.
Garofalo F., di Summa P.G., Christoforidis D., Pracht M., Laudato P., Cherix S., Bouchaab H., Raffoul W., Demartines N., Matter M., 2015. Journal of Surgical Oncology, 112 (5) pp. 544-554. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0E65A7CA68CA]
 
Méta-analyses d'essais randomisés sur données individuelles dans le traitement des cancers ORL non métastatiques : principes, résultats, perspectives [Individual patient data meta-analyses of randomized trials for the treatment of non-metastatic head and neck squamous cell carcinomas: Principles, results and perspectives].
Blanchard P., Bourhis J., Lacas B., Le Teuff G., Michiels S., Pignon J.P., 2015. Cancer Radiothérapie, 19 (3) pp. 198-204. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7A5B3B569B28]
 
Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.
Giralt J., Trigo J., Nuyts S., Ozsahin M., Skladowski K., Hatoum G., Daisne J.F., Yunes Ancona A.C., Cmelak A., Mesía R. et al., 2015. Lancet. Oncology, 16 (2) pp. 221-232. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7F0E8D497F06]
Patterns of practice of regional nodal irradiation in breast cancer: results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal Radiotherapy (NORA) survey.
Belkacemi Y., Kaidar-Person O., Poortmans P., Ozsahin M., Valli M.C., Russell N., Kunkler I., Hermans J., Kuten A., van Tienhoven G. et al., 2015. Annals of Oncology, 26 (3) pp. 529-535. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_38D91B4228D2]
 
Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study.
Harrington K., Temam S., Mehanna H., D'Cruz A., Jain M., D'Onofrio I., Manikhas G., Horvath Z., Sun Y., Dietzsch S. et al., 2015. Journal of Clinical Oncology, 33 (35) pp. 4202-4209. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DCBE8F3CEAC4]
Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial.
Azria D., Riou O., Castan F., Nguyen T.D., Peignaux K., Lemanski C., Lagrange J.L., Kirova Y., Lartigau E., Belkacemi Y. et al., 2015. Ebiomedicine, 2 (12) pp. 1965-1973. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FAEEE27F5350]
 
Radiothérapie « flash » à très haut débit de dose : un moyen d'augmenter l'indice thérapeutique par minimisation des dommages aux tissus sains  [Ultrahigh dose-rate, "flash" irradiation minimizes the side-effects of radiotherapy].
Favaudon V., Fouillade C., Vozenin M.C., 2015. Cancer Radiothérapie, 19 (6-7) pp. 526-531. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DB62B032CBBA]
 
Re: Nazareno Suardi, Andrea Gallina, Giuliana Lista, et al. Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy. Eur urol 2014;65:546-51.
De Bari B., Arcangeli S., Alongi F., 2015. European Urology, 67 (2) pp. e26.
[DOI][WoS][Pmid][serval:BIB_F1FDA2CF944D]
 
Research Progress in Head and Neck Squamous Cell Carcinoma: Best Abstracts of ICHNO 2015.
Economopoulou P., Bourhis J., Psyrri A., 2015. American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting pp. e323-e328. Peer-reviewed.
[DOI][Pmid][serval:BIB_67B8AEDDA73E]
 
SBRT and extreme hypofractionation: A new era in prostate cancer treatments?
Alongi F., Fiorentino A., De Bari B., 2015. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 20 (6) pp. 411-416.
[DOI][Pmid][serval:BIB_47AFDD9A5823]
Simultaneous irradiation of fibroblasts and carcinoma cells repress the secretion of soluble factors able to stimulate carcinoma cell migration.
Arshad A., Deutsch E., Vozenin M.C., 2015. Plos One, 10 (1) pp. e0115447. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D4674EB69701]
 
Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients.
Pasquier D., Barney B., Sundar S., Poortmans P., Villa S., Nasrallah H., Boujelbene N., Ghadjar P., Lassen-Ramshad Y., Senkus E. et al., 2015. International Journal of Radiation Oncology, Biology, Physics, 92 (4) pp. 904-910. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B0FF16B354ED]
 
Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck Cancer.
Mondini M., Nizard M., Tran T., Mauge L., Loi M., Clémenson C., Dugue D., Maroun P., Louvet E., Adam J. et al., 2015. Molecular Cancer Therapeutics, 14 (6) pp. 1336-1345. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_12931D59EDB4]
 
The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma.
Matzinger O., Viertl D., Tsoutsou P., Kadi L., Rigotti S., Zanna C., Wiedemann N., Vozenin M.C., Vuagniaux G., Bourhis J., 2015. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology, 116 (3) pp. 495-503. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BFF3A5A037D6]
 
Trigeminal Neuralgia Secondary to Intracranial Lesions: A Prospective Series of 17 Consecutive Cases
Schwyzer L., Tuleasca C., Schiappacasse L., Zeverino M., Fandino J., Levivier M., 2015. pp. P067 dans Joint Annual Meeting 2015: Swiss Society of Neurosurgery and Swiss Society of Neuroradiology Together with IG-NOPPS, Journal of Neurological Surgery Part A: Central European Neurosurgery.
[DOI][serval:BIB_ADECA900BC11]
 
Tumor-infiltrating lymphocytes in triple-negative breast cancer: a biomarker for use beyond prognosis?
Tsoutsou P.G., Bourhis J., Coukos G., 2015. Journal of Clinical Oncology, 33 (11) pp. 1297-1298. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0DCE380A0052]
2014
 
Carotid Dose Sparing in Definitive Irradiation of Early-Stage Glottic Cancer Using Helical Tomotherapy–Based Image-Guided Intensity Modulated Radiation Therapy
Ozsahin E., Cosinschi A., Bouchaab H., Soares Rodrigues J.L., Péguret N., De Bari B., Schiappacasse L., Vallet V., Pasche P., Simon C. et al., 2014/09. International Journal of Radiation Oncology*Biology*Physics, 90 (1) pp. S534.
[DOI][WoS][serval:BIB_E81B046598F5]
 
La radiothérapie postopératoire a-t-etlle une place dans le cancer pulmonaire ? [Postoperative radiation therapy in lung carcinom]
Bouchaab H., Peters S., Ozsahin M., Peguret N., Gonzales M., Lovis A., 2014/05/21. Revue medicale suisse, 10 (431) pp. 1110-1113. Peer-reviewed.
[Pmid][serval:BIB_58D9608BE954]
 
MiR-210: A potential therapeutic target against radiation-induced enteropathy.
Hamama S., Noman M.Z., Gervaz P., Delanian S., Vozenin M.C., 2014/05. Radiotherapy and oncology, 111 (2) pp. 219-221. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_13C211EFA686]
 
[(18)F]FDG-PET Standard Uptake Value as a Metabolic Predictor of Bone Marrow Response to Radiation: Impact on Acute and Late Hematological Toxicity in Cervical Cancer Patients Treated With Chemoradiation Therapy.
Elicin O., Callaway S., Prior J.O., Bourhis J., Ozsahin M., Herrera F.G., 2014. International Journal of Radiation Oncology, Biology, Physics, 90 (5) pp. 1099-1107. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9B5C992E8C1E]
Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
Burtness B., Bourhis J.P., Vermorken J.B., Harrington K.J., Cohen E.E., 2014. Trials, 15 p. 469.
[URN][DOI][WoS][Pmid][serval:BIB_BB40A9A07883]
 
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society.
Pegurri L., Buglione M., Girelli G., Guarnieri A., Meattini I., Ricardi U., Mangoni M., Gabriele P., Bellavita R., Krengli M. et al., 2014. Tumori, 100 (1) pp. 31-37. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5490ED9CF7C8]
 
Choline-PET in prostate cancer management: The point of view of the radiation oncologist.
De Bari B., Alongi F., Lestrade L., Giammarile F., 2014. Critical Reviews In Oncology/hematology, 91 (3) pp. 234-247. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_03EC902CE5FE]
 
Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas. Strahlentherapie in Kombination mit platinbasierter Chemotherapie oder Cetuximab zur Behandlung von lokal fortgeschrittenen Plattenepithelkarzinomen im Kopf-Hals-Bereich.
Levy A., Blanchard P., Bellefqih S., Brahimi N., Guigay J., Janot F., Temam S., Bourhis J., Deutsch E., Daly-Schveitzer N. et al., 2014. Strahlentherapie Und Onkologie, 190 (9) pp. 823-831. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CAACDC1DE8DE]
 
Could single-high-dose radiotherapy be considered the new frontier of stereotactic ablative radiation therapy?
Alongi F., De Bari B., Scorsetti M., 2014. Tumori, 100 (3) pp. e92-e93.
[DOI][Pmid][serval:BIB_B773EFA504BC]
 
Critères de qualité en radiothérapie des cancers de la tête et du cou sous l'égide de l'Intergroupe ORL Quality criteria in radiotherapy for head and neck cancers under the aegis of Head and Neck Intergroup.
Tao Y., Vintonenko N., Garcia R., Marchesi V., Tomsej M., Bardet E., Bourhis J., 2014. Bulletin du Cancer, 101 (5) pp. 481-485.
[DOI][WoS][Pmid][serval:BIB_F8617DF47057]
 
Dramatic malignant progression of a pigmented villonodular synovitis of the knee after 27 years of multimodality treatment
Cherix S., Matter M., Gay B., Becce F., Matzinger O., Letovanec I., Stanekova K., Rüdiger HA, 2014. dans 73. Congrès Annuel de la Société Suisse d'Orthopédie et de Traumatologie.
[serval:BIB_9965B11622FF]
 
Early investigational drugs that target epidermal growth factor receptors for the treatment of head and neck cancer.
Ugurluer G., Ozsahin M., 2014. Expert Opinion on Investigational Drugs, 23 (12) pp. 1637-1654. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5FCAF852B7A1]
 
Epac contributes to cardiac hypertrophy and amyloidosis induced by radiotherapy but not fibrosis.
Monceau V., Llach A., Azria D., Bridier A., Petit B., Mazevet M., Strup-Perrot C., To T.H., Calmels L., Germaini M.M. et al., 2014. Radiotherapy and Oncology, 111 (1) pp. 63-71. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AF47671526E1]
 
External beam radiotherapy ± chemotherapy in the treatment of anal canal cancer: a single-institute long-term experience on 100 patients.
De Bari B., Buglione M., Maddalo M., Lestrade L., Spiazzi L., Vitali P., Barbera F., Magrini S.M., 2014. Cancer Investigation, 32 (6) pp. 248-255. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A0906D2DB6A7]
 
Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas.
Levy A., Blanchard P., Bellefqih S., Brahimi N., Guigay J., Janot F., Temam S., Daly-Schveitzer N., Bourhis J., Tao Y., 2014. Anti-cancer Drugs, 25 (10) pp. 1220-1226. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9E0ACFD8EED0]
 
Four years with FALCON - an ESTRO educational project: achievements and perspectives.
Eriksen J.G., Salembier C., Rivera S., De Bari B., Berger D., Mantello G., Müller A.C., Martin A.N., Pasini D., Tanderup K. et al., 2014. Radiotherapy and Oncology, 112 (1) pp. 145-149. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3F19F2C3D80C]
Fragment N2, a caspase-3-generated RasGAP fragment, inhibits breast cancer metastatic progression
Barras D., Lorusso G., Lhermitte B., Viertl D., Rüegg C., Widmann C., 2014. International Journal of Cancer. Journal International Du Cancer, 135 (1) pp. 242-247. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1FACF08B8A65]
 
From radiobiology to technology: what is changing in radiotherapy for prostate cancer.
De Bari B., Fiorentino A., Arcangeli S., Franco P., D'Angelillo R.M., Alongi F., 2014. Expert Review of Anticancer Therapy, 14 (5) pp. 553-564. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8A495E1A7F50]
High-grade gliomas: reality and hopes.
Mirimanoff R.O., 2014. Chinese Journal of Cancer, 33 (1) pp. 1-3.
[URN][DOI][WoS][Pmid][serval:BIB_B5189D699B87]
History of the rare cancer network and past research.
Mirimanoff R.O., Ozsahin M., Thariat J., Ozyar E., Schick U., Pehlivan B., Krengli M., Pellanda A.F., Vees H., Cai L. et al., 2014. Rare Tumors, 6 (3) p. 5462. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D2A320CA5C0D]
 
Le réseau international des cancers rares [RCN, Rare Cancer Network].
Mirimanoff R.O., Thariat J., Belkacemi Y., Villa S., Ozyar E., Krengli M., Miller R.C., Ozsahin M., le Rare Cancer Network Oncologie radiothérapie, 2014. Bulletin Du Cancer, 101 (9) pp. 778-779.
[DOI][WoS][Pmid][serval:BIB_8FB1E7CE4723]
 
Living-engineered valves for transcatheter venous valve repair.
Weber B., Robert J., Ksiazek A., Wyss Y., Frese L., Slamecka J., Kehl D., Modregger P., Peter S., Stampanoni M. et al., 2014. Tissue Engineering. Part C, Methods, 20 (6) pp. 451-463. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5304A78C318C]
Long-term Outcome and Late Side Effects in Endometrial Cancer Patients Treated with Surgery and Postoperative Radiation Therapy.
Herrera F.G., Cruz O.S., Achtari C., Bourhis J., Ozsahin M., 2014. Annals of Surgical Oncology, 21 (7) pp. 2390-2397.
[URN][DOI][WoS][Pmid][serval:BIB_9652529431A0]
Long-Term Remission of an Aggressive Sebaceous Carcinoma following Chemotherapy
Orcurto A., Gay B.E., Sozzi W.J., Gilliet M., Leyvraz S., 2014. Case Reports In Dermatology, 6 (1) pp. 80-84. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_23C00DC9C10C]
 
Prise en charge des cancers du cavum (rhinopharynx) Nasopharyngeal cancers, an overview.
Jardel P., Thariat J., Blanchard P., Elloumi F., Toumi N., Bensadoun R.J., Frikha M., Daoud J., Bourhis J., 2014. Bulletin du Cancer, 101 (5) pp. 445-454.
[DOI][WoS][Pmid][serval:BIB_0A629EE69270]
 
Radiation-induced sequelae measured by lymphocyte apoptosis: in regard to Foro et al.
Ozsahin M., Azria D., 2014. International Journal of Radiation Oncology, Biology, Physics, 90 (2) p. 470. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_481B2B7D4044]
 
Re: Cesare Cozzarini, Claudio Fiorino, Chiara Deantoni, et al. Higher-than-expected severe (grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients. Eur urol 2014;66:1024-30.
De Bari B., Alongi F., Arcangeli S., 2014. European Urology, 66 (6) pp. e111-e112.
[DOI][WoS][Pmid][serval:BIB_3B78BB9ACC52]
 
Reply to D. Tural et al.
Blanchard P., Bourhis J., Pignon J.P., 2014. Journal of Clinical Oncology, 32 (3) pp. 259-260.
[DOI][WoS][Pmid][serval:BIB_D9F530613565]
Role of brachytherapy in the treatment of cancers of the anal canal. Long-term follow-up and multivariate analysis of a large monocentric retrospective series.
Lestrade L., De Bari B., Pommier P., Montbarbon X., Lavergne E., Ardiet J.M., Carrie C., 2014. Strahlentherapie Und Onkologie, 190 (6) pp. 546-554.
[URN][DOI][WoS][Pmid][serval:BIB_4CC0399FAB1E]
 
Salvage therapy of small volume prostate cancer nodal failures: a review of the literature.
De Bari B., Alongi F., Buglione M., Campostrini F., Briganti A., Berardi G., Petralia G., Bellomi M., Chiti A., Fodor A. et al., 2014. Critical Reviews In Oncology/hematology, 90 (1) pp. 24-35.
[DOI][Pmid][serval:BIB_0B81C14B4A93]
 
Tailored Radiosurgical Planning of Skull-Base Meningiomas in the Era of Gamma Knife Perfexion: A Prospective Series of 100 Consecutive Cases
Tuleasca C., Schwyzer L., Schiappacasse L., Zeverino M., Daniel R.T., Levivier M., 2014. p. 78 dans Joint Annual Meeting 2014 of Swiss Society of Neurosurgery and Swiss Society of Clinical Neurophysiology, Swiss Society of Neuropediatrics Together with Association of neurosurgical nursing staff Switzerland and Swiss Association for Diagnostical Neurophysiology, Journal of Neurological Surgery Part A: Central European Neurosurgery.
[DOI][serval:BIB_18159FE37D04]
 
The interplay between radiation and the immune system in the field of post-radical pneumonitis and fibrosis and why it is important to understand it.
Tsoutsou P.G., 2014. Expert Opinion On Pharmacotherapy, 15 (13) pp. 1781-1783.
[DOI][WoS][Pmid][serval:BIB_DF38FB32277B]
 
The PEDRO (Pocketable Electronic Devices in Radiation Oncology) project: how clinical practice is changing among young radiation oncologists.
De Bari B., Franco P., Ciammella P., Peruzzo Cornetto A., Greto D., Fundoni C., Filippi A.R., Alongi F., AIRO Giovani (Italian Association of Radiation Oncology-Young Members Working Group), 2014. Tumori, 100 (6) pp. 236e-242e. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B96681148BCF]
The rare cancer network: ongoing studies and future strategy.
Ozsahin M., Mirimanoff R.O., Thariat J., Sun X.S., Atalar B., Lassen-Ramshad Y., Ugurluer G., Krishnan S., Hallemeier C., Houtte P.V. et al., 2014. Rare Tumors, 6 (3) p. 5465. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B27A9B65E103]
 
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani).
Franco P., De Bari B., Ciammella P., Fiorentino A., Chiesa S., Amelio D., Pinzi V., Bonomo P., Vagge S., Fiore M. et al., 2014. Tumori, 100 (6) pp. 214e-229e. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C4337AE01147]
 
Toxicity of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: a potential comparison bias.
Arcangeli S., De Bari B., Alongi F., 2014. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 32 (30) p. 3454. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2856789C6CBC]
 
Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice.
Favaudon V., Caplier L., Monceau V., Pouzoulet F., Sayarath M., Fouillade C., Poupon M.F., Brito I., Hupé P., Bourhis J. et al., 2014. Science Translational Medicine, 6 (245) pp. 245ra93. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6BEAFB335D2A]
2013
 
Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer.
Lartigau E.F., Tresch E., Thariat J., Graff P., Coche-Dequeant B., Benezery K., Schiappacasse L., Degardin M., Bondiau P.Y., Peiffert D. et al., 2013/11. Radiotherapy and Oncology, 109 (2) pp. 281-285. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EB4E246EC6D3]
 
PD-0575: How accurate a segmentation could be? Evaluation of consistence and coherence of an elastic deformation algorithm
Schiappacasse L., Viard R., Gibon D., Lacornerie T., Leroy T., Lodron G., Vasseur F., Lartigau E., 2013/03. pp. S220-S221 dans 2nd ESTRO Forum 19-23 April 2013, Geneva, Switzerland, Radiotherapy and Oncology .
[DOI][serval:BIB_3FDB2F2361A1]
 
Nomograms predicting locoregional recurrence in the subtype era of breast cancer.
Tsoutsou P.G., Jeanneret Sozzi W., Matzinger O., Ozsahin M., 2013/02/10. Journal of clinical oncology, 31 (5) pp. 647-648. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EEB77FCDD35C]
 
Adenosquamous carcinoma of the head and neck: report of 20 cases and review of the literature.
Schick U., Pusztaszeri M., Betz M., Ghadjar P., Demiroz C., Kaanders J.H., Ozsahin M., 2013. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 116 (3) pp. 313-320. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8C325269EDBB]
Assessment of needs, health-related quality of life, and satisfaction with care in breast cancer patients to better target supportive care.
Brédart A., Kop J.L., Griesser A.C., Fiszer C., Zaman K., Panes-Ruedin B., Jeanneret W., Delaloye J.F., Zimmers S., Berthet V. et al., 2013. Annals of Oncology, 24 (8) pp. 2151-2158. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_75896E44EE85]
 
Bio-radiation dermatitis: the need of a new grading: in regard to Bernier et al: Ann Oncol 2011; 22(10): 2191-2200.
Russi E.G., Bensadoun R.J., Merlano M.C., Bourhis J., Ricardi U., Giralt J., Pinto C., Budach W., Corvo R., Lacouture M.E. et al., 2013. Annals of Oncology, 24 (9) pp. 2463-2465.
[DOI][WoS][Pmid][serval:BIB_F81F450E1D31]
 
Centre de la prostate: une approche multidisciplinaire pour une prise en charge globale du patient [Prostate cancer center: a multidisciplinary approach to accurately manage patients with prostate cancer]
Tawadros T., Burruni R., Herrera F., Codeluppi C., Zurkinden C., Meuwly J.Y., Lhermitte B., Berthold D., 2013. Revue Médicale Suisse, 9 (409) pp. 2270-2, 2274.
[Pmid][serval:BIB_AA917B8978EC]
 
Combined approaches in large vestibular schwannomas: surgical and radiosurgical perspective
Daniel R.T., Tuleasca C., Negretti L., Magaddino M., George M., Levivier M., 2013. p. 157 dans 11th International Stereotactic Radiosurgery Society Congress, Journal of Radiosurgery and SBRT.
[serval:BIB_E7B02E2D98E7]
Consolidation whole abdomen irradiation following adjuvant carboplatin-paclitaxel based chemotherapy for advanced uterine epithelial cancer: feasibility, toxicity and outcomes.
Rochet N., Kahn R.S., Niemierko A., Delaney T.F., Russell A.H., 2013. Radiation Oncology, 8 (1) p. 236. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F91E6FDA9FE8]
 
Effects of computing parameters and measurement locations on the estimation of 3D NPS in non-stationary MDCT images.
Miéville F.A., Bolard G., Bulling S., Gudinchet F., Bochud F.O., Verdun F.R., 2013. Physica Medica, 29 (6) pp. 684-694.
[DOI][WoS][Pmid][serval:BIB_E964145973FE]
 
Evaluation of organ-specific peripheral doses after 2-dimensional, 3-dimensional and hybrid intensity modulated radiation therapy for breast cancer based on Monte Carlo and convolution/superposition algorithms: implications for secondary cancer risk assessment.
Joosten A., Matzinger O., Jeanneret-Sozzi W., Bochud F., Moeckli R., 2013/01. Radiotherapy and oncology, 106 (1) pp. 33-41. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2E35C2D6242A]
 
Immunothérapie: une nouvelle arme contre le cancer de la prostate [Immunotherapy: a therapeutic revolution against prostate cancer?].
Pracht M., Herrera F.G, Tawadros T., Berthold D., 2013. Revue Médicale Suisse, 9 (387) pp. 1070-1075. Peer-reviewed.
[Pmid][serval:BIB_872CCC33F242]
 
Impact of induction therapy on airway complications after sleeve lobectomy for lung cancer.
Gonzalez M., Litzistorf Y., Krueger T., Popeskou S.G., Matzinger O., Ris H.B., Gronchi F., Lovis A., Peters S., 2013. Annals of Thoracic Surgery, 96 (1) pp. 247-252. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EA67B4B310DD]
 
Post-detection analysis for grating-based ultra-small angle X-ray scattering.
Scattarella F., Tangaro S., Modregger P., Stampanoni M., De Caro L., Bellotti R., 2013. Physica Medica, 29 (5) pp. 478-486. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_82F9746922E2]
 
Prostate cancer as a paradigm of multidisciplinary approach? Highlights from the Italian young radiation oncologist meeting.
De Bari B., Fiorentino A., Greto D., Ciammella P., Arcangeli S., Avuzzi B., D'Angelillo R.M., Desideri I., Kirienko M., Marchiori D. et al., 2013. Tumori, 99 (6) pp. 637-649. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EEE7315FFC10]
 
Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: Results of the Dummy Run procedure.
Fenton P.A., Hurkmans C., Gulyban A., van der Leer J., Matzinger O., Poortmans P., Collette L., Bolla M., 2013. Radiotherapy and Oncology, 107 (3) pp. 346-351.
[DOI][WoS][Pmid][serval:BIB_6DF9D65A295F]
 
Radiosensibilité individuelle : les tests vont changer nos pratiques [Intrinsic radiosensitivity: predictive assays that will change the daily practice].
Lacombe J., Riou O., Solassol J., Mangé A., Bourgier C., Fenoglietto P., Pèlegrin A., Ozsahin M., Azria D., 2013. Cancer Radiothérapie, 17 (5-6) pp. 337-343.
[DOI][WoS][Pmid][serval:BIB_31527A9EF138]
 
Radiotherapy options after breast-conserving surgery: how can selection of patients be refined?
Tsoutsou P.G., Jeanneret Sozzi W., Ozsahin M., Delaloye J.F., Bourhis J., 2013. Journal of Clinical Oncology, 31 (36) pp. 4570-4571. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C8D10DF8C575]
 
Recurrence due to neoplastic seeding in head and neck cancer: report of two cases and review of the literature.
Nisa L., Khanfir K., Giger R., 2013. Tumori, 99 (4) pp. e144-7. Peer-reviewed.
[DOI][Pmid][serval:BIB_EC72F2CAC8EA]
Retrospective feasibility study of simultaneous integrated boost in cervical cancer using Tomotherapy: the impact of organ motion and tumor regression.
Herrera F.G., Callaway S., Delikgoz-Soykut E., Coskun M., Porta L., Meuwly J.Y., Soares-Rodrigues J., Heym L., Moeckli R., Ozsahin M., 2013. Radiation Oncology, 8 (5) pp. 1-10. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A4AEBB0F5438]
Stereotactic body radiation therapy in stage I inoperable lung cancer: from palliative to curative options.
Boujelbene N., Elloumi F., Kamel M.E., Abeidi H., Matzinger O., Mirimanoff R.O., Khanfir K., 2013. Swiss Medical Weekly, 143 pp. w13780.
[URN][DOI][WoS][Pmid][serval:BIB_25F45DB80F37]
 
Tailored radiosurgical planning in vestibular schwannomas in the era of Gamma Knife Perfexion: a prospective series of 117 cases
Tuleasca C., George M., Dubourg J., Negretti L., Ghandour S., Maire R., Levivier M., 2013. dans SFCNS 2013, 2nd Congress Swiss Federation of Clinical Neuro-Societies.
[serval:BIB_E5CB8F961DD1]
 
Technical nuances in Gamma Knife radiosurgery for trigeminal neuralgia: How we do it. Experience in a series of 14 consecutive patients
Levivier M., Tuleasca C., Bloch J., Ghandour S., Negretti L., 2013. dans SFCNS 2013, 2nd Congress Swiss Federation of Clinical Neuro-Societies.
[serval:BIB_8AE2CEA9A143]
 
The Effect of Amifostine on Acute and Late Radiation Side Effects in Head and Neck Cancer Patients
Demiroz C., Ozkan L., Cebelli G., Karadag O., Ozsahin E.M., 2013. Turkiye Klinikleri Tip Bilimleri Dergisi, 32 (5) pp. 1207-1216.
[DOI][WoS][serval:BIB_7DBE15E9107D]
The role of PET/CT in cervical cancer.
Herrera F.G., Prior J.O., 2013. Frontiers in Oncology, 3 p. 34.
[URN][DOI][Pmid][serval:BIB_A37E9045E6C9]
The use of PET/CT in radiotherapy planning: contribution of deformable registration.
Delikgoz Soykut E., Ozsahin E.M., Yukselen Guney Y., Aytac Arslan S., Derinalp Or O., Altundag M.B., Ugurluer G., Tsoutsou P.G., 2013. Frontiers In Oncology, 3 p. 33. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C6E2180DCFA9]
2012
 
Les esthésioneuroblastomes [Esthesioneuroblastoma]
Elloumi F., Boujelbene N., Ghorbal L., Boujelbene N., Khanfir K., Mirimanoff R.O., Daoud J., 2012/12. Bulletin du cancer, 99 (12) pp. 1197-1207. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DFC1D530F934]
 
TEP/TDM en radiothérapie : indications et perspectives [PET/CT and radiotherapy: indications and potential applications]
Rossier C., Dunet V., Matzinger O., Prior J.O., 2012/04. Cancer radiotherapie , 16 (2) pp. 152-163. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FAC74D1F6CA4]
 
18F-FLT and 125I-IdUrd uptake increase in human tumour cell lines induced by the thymidylate synthase inhibitor FdUrd.
Viertl D., Perillo-Adamer F., André P.A., Ametamey S.M., Ross T.L., Kosinski M., Dupertuis Y.M., Bischof Delaloye A., Buchegger F., 2012. Nuklearmedizin. Nuclear Medicine, 51 (5) pp. 163-169. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_85018DF7729E]
 
A stepwise protocol to coat aAPC beads prevents out-competition of anti-CD3 mAb and consequent experimental artefacts.
Fuertes Marraco S.A., Baumgaertner P., Legat A., Rufer N., Speiser D.E., 2012. Journal of Immunological Methods, 385 (1-2) pp. 90-95.
[DOI][WoS][Pmid][serval:BIB_101C0CB4CDE2]
 
Accelerated Hypofractionated radiotherapy in inoperable lung cancer using tomotherapy : the Lausanne experience
Bouchaab H., Peters S., Ris H.B., Tsoutsou P., Mirimanoff R.O., Ozsahin M., Matzinger O., 2012. dans ELCC 2012, 3rd European Lung Cancer Conference.
[serval:BIB_37B9AFA6ACE0]
 
Assessment of the novel tubulin-binding agent EHT 6706 in combination with ionizing radiation or chemotherapy.
Clémenson C., Chargari C., Désiré L., Casagrande A.S., Bourhis J., Deutsch E., 2012. Investigational New Drugs, 30 (6) pp. 2173-2186.
[DOI][Pmid][serval:BIB_894943E6CA8F]
 
Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy.
Van der Kwast T., Al Daoud N., Collette L., Sykes J., Thoms J., Milosevic M., Bristow R.G., Van Tienhoven G., Warde P., Mirimanoff R.O. et al., 2012. European Journal of Cancer, 48 (9) pp. 1318-1325.
[DOI][WoS][Pmid][serval:BIB_3810FB48D013]
 
Cavernomas and brain cysts as treatment-related sequelae in survivors of pediatric brain tumors
Casutt Alessio, Maeder Philippe, Negretti Laura, Beck-Popovic Maja, 2012. p. 1102 dans 44th Congress of the International Society of Paediatric Oncology (SIOP) 2012, Pediatric Blood & Cancer.
[WoS][serval:BIB_E129C51DFE5B]
 
Clinical review--breast adenoid cystic carcinoma.
Boujelbene N., Khabir A., Boujelbene N., Jeanneret Sozzi W., Mirimanoff R.O., Khanfir K., 2012. Breast, 21 (2) pp. 124-127.
[DOI][WoS][Pmid][serval:BIB_A44F426169FC]
 
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial.
Bourhis J., Sire C., Graff P., Grégoire V., Maingon P., Calais G., Gery B., Martin L., Alfonsi M., Desprez P. et al., 2012. Lancet Oncology, 13 (2) pp. 145-153. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_832A983D2A62]
 
Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).
Ghadjar P., Simcock M., Studer G., Allal A.S., Ozsahin M., Bernier J., Töpfer M., Zimmermann F., Betz M., Glanzmann C. et al., 2012. International Journal of Radiation Oncology, Biology, Physics, 82 (2) pp. 524-531.
[DOI][WoS][Pmid][serval:BIB_281A4BFB6542]
 
Definitive organ-sparing treatment of anal canal cancer: can we afford to question it?
Ozsahin M., Santa Cruz O., Bouchaab H., Matzinger O., Tsoutsou P.G., 2012. Journal of Clinical Oncology, 30 (6) pp. 673-675.
[DOI][WoS][Pmid][serval:BIB_0DC9B2091652]
 
Early-Stage Primary Bone Lymphoma: A Retrospective, Multicenter Rare Cancer Network (RCN) Study.
Cai L., Stauder M.C., Zhang Y.J., Poortmans P., Li Y.X., Constantinou N., Thariat J., Kadish S.P., Nguyen T.D., Kirova Y.M. et al., 2012. International Journal of Radiation Oncology, Biology, Physics, 83 (1) pp. 284-291.
[DOI][WoS][Pmid][serval:BIB_D5857DBFA0C5]
 
EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facility.
Fairchild A., Aird E., Fenton P.A., Gregoire V., Gulyban A., Lacombe D., Matzinger O., Poortmans P., Ruyskart P., Weber D.C. et al., 2012. Radiotherapy and Oncology, 103 (3) pp. 279-286.
[DOI][WoS][Pmid][serval:BIB_2523BE49D38A]
 
EORTC topics in neurooncology: The long path from a focus on neurological complications of cancer towards molecularly defined trials and therapies in neurooncology
Wicka Wolfgang, van den Bentb Martin, Vechtc Charles, Brandesd Alba, Lacombee Denis, Gorliae Thierry, Allgeiere Anouk, Baumertf Brigitta G., Soffiettig Riccardo, Sansonh Marc et al., 2012. European Journal of Cancer Supplements, 10 (Suppl. 1) pp. 20-26. Peer-reviewed.
[DOI][serval:BIB_BD86E9565411]
 
Impact of lung function changes after induction radiochemotherapy on resected T4 non-small cell lung cancer outcome.
Perentes J., Bopp S., Krueger T., Gonzalez M., Jayet P.Y., Lovis A., Matzinger O., Ruffieux C., Ris H.B., Letovanec I. et al., 2012. Annals of Thoracic Surgery, 94 (6) pp. 1815-1822. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DDD65796959F]
 
Impact of Prophylactic Cranial Irradiation Timing on Brain Relapse Rates in Patients With Stage IIIB Non-Small-Cell Lung Carcinoma Treated With Two Different Chemoradiotherapy Regimens.
Topkan E., Parlak C., Kotek A., Yuksel O., Cengiz M., Ozsahin M., Pehlivan B., 2012. International Journal of Radiation Oncology, Biology, Physics, 83 (4) pp. 1264-1271.
[DOI][WoS][Pmid][serval:BIB_408E90866DE9]
 
Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy.
Kuonen F., Laurent J., Secondini C., Lorusso G., Stehle J.C., Rausch T., Faes-Van't Hull E., Bieler G., Alghisi G.C., Schwendener R. et al., 2012. Clinical Cancer Research, 18 (16) pp. 4365-4374.
[DOI][WoS][Pmid][serval:BIB_C17B78774AD2]
 
Longer Intervals Between Hematopoietic Stem Cell Transplantation and Subsequent 90Y-Ibritumomab Radioimmunotherapy May Correlate With Better Tolerance.
Buchegger F., Prior J.O., Allenbach G., Baechler S., Kosinski M., Helg C., Chalandon Y., Ratib O., Delaloye A.B., Ketterer N., 2012. Clinical Nuclear Medicine, 37 (10) pp. 960-964.
[DOI][WoS][Pmid][serval:BIB_83B300886ED1]
 
Loss of Cutaneous TSLP-Dependent Immune Responses Skews the Balance of Inflammation from Tumor Protective to Tumor Promoting.
Di Piazza M., Nowell C.S., Koch U., Durham A.D., Radtke F., 2012. Cancer Cell, 22 (4) pp. 479-493.
[DOI][WoS][Pmid][serval:BIB_001897BAC121]
 
Management of adenoid cystic carcinoma of the breast: a Rare Cancer Network study.
Khanfir K., Kallel A., Villette S., Belkacémi Y., Vautravers C., Nguyen T., Miller R., Li Y.X., Taghian A.G., Boersma L. et al., 2012. International Journal of Radiation Oncology, Biology, Physics, 82 (5) pp. 2118-2124. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C49765726A0F]
 
Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?
Zilli T., Schick U., Ozsahin M., Gervaz P., Roth A.D., Allal A.S., 2012. Radiotherapy and Oncology, 102 (1) pp. 62-67.
[DOI][WoS][Pmid][serval:BIB_604964E43F26]
 
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03).
Pesce G.A., Klingbiel D., Ribi K., Zouhair A., von Moos R., Schlaeppi M., Caspar C.B., Fischer N., Anchisi S., Peters S. et al., 2012. European Journal of Cancer, 48 (3) pp. 377-384.
[DOI][WoS][Pmid][serval:BIB_417EF1578C3A]
 
Planned Subtotal Resection in Benign Skull Base Tumors Followed by Gamma Knife Surgery: Preliminary Results
Tuleasca C., Levivier M., Negretti L., Magaddino V., Daniel R., 2012. pp. P047 dans Joint Meeting of the Swiss Society of Neurosurgery, the Society of British Neurological Surgeons and the Association of Neurosurgical Nursing Staff Switzerland, Journal of Neurological Surgery Part A.
[DOI][serval:BIB_18926343F4F1]
 
Planned subtotal resection in large skull base meningiomas followed by Gamma Knife radiosurgery: preliminary results
Daniel R.T., Tuleasca C., Negretti L., Magaddino V., Levivier M., 2012. pp. iii69- iii70 dans 10th Congress of European Association of NeuroOncology, Neuro-Oncology.
[serval:BIB_2FE9BEE6287C]
Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial.
Hegi M.E., Janzer R.C., Lambiv W.L., Gorlia T., Kouwenhoven M.C., Hartmann C., von Deimling A., Martinet D., Besuchet Schmutz N., Diserens A.C. et al., 2012. Acta Neuropathologica, 123 (6) pp. 841-852. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6613022C4BFB]
 
Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: a multicenter Rare Cancer Network study.
Anacak Y., Miller R.C., Constantinou N., Mamusa A.M., Epelbaum R., Li Y., Calduch A.L., Kowalczyk A., Weber D.C., Kadish S.P. et al., 2012. International Journal of Radiation Oncology, Biology, Physics, 82 (1) pp. 315-320.
[DOI][WoS][Pmid][serval:BIB_87086484BE22]
 
Primary pineal tumors: outcome and prognostic factors-a study from the Rare Cancer Network (RCN).
Villà S., Miller R.C., Krengli M., Abusaris H., Baumert B.G., Servagi-Vernat S., Igdem S., Lucas A., Boluda S., Mirimanoff R.O., 2012. Clinical and Translational Oncology, 14 (11) pp. 827-834. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0D387B956D61]
 
Prognostic factors and role of adjuvant therapies in the management of parasagittal meningiomas
Villard J., Robert T., Pica A., Mirimanoff R.O., Levivier M., Bloch J., 2012. Journal of Radiosurgery and SBRT, 1 (4) pp. 287-294. Peer-reviewed.
[serval:BIB_974A15F7601C]
 
Recommandations pour la prise en charge du mélanome
Bron L., Cerottini J.P., Dietrich P.Y., Gugerli O., Guggisberg D., Legal F.A., Matter M., Matzinger O., Michielin O., Voelte V., 2012., 3e édition [44], Groupe Mélanome Lémanique.
[serval:BIB_9562D3561A74]
Relapsed seminoma during surveillance: first treatment choice should be radiotherapy.
Herrera F., Berthold D.R., 2012. Journal of Clinical Oncology, 30 (16) pp. 2021; author reply 2022. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_121A7BF04541]
 
Response to "Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy." (Int J Radiat Oncol Biol Phys 2011;80:398-402).
Tsoutsou P.G., Jeanneret Sozzi W., Ozsahin M., 2012. International Journal of Radiation Oncology, Biology, Physics, 82 (2) p. 519.
[DOI][WoS][Pmid][serval:BIB_127225E3B7E4]
The Rare Cancer Network: achievements from 1993 to 2012.
Patel A., Ozsahin M., Mirimanoff R.O., Bhatia S., Chang K., Miller R.C., 2012. Rare Tumors, 4 (3) pp. e35.
[URN][DOI][Pmid][serval:BIB_29A86767B2F1]
 
Usefulness of intra-articular bupivacain and lidocain adjunction in MR or CT arthrography: a prospective study in 148 patients.
Mosimann P.J., Richarme D., Becce F., Knoepfli A.S., Mino V., Meuli R., Theumann N., 2012. European Journal of Radiology, 81 (9) pp. e957-e961. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5A70762C1B03]
2011
 
3D Ultrasound Tumor Segmentation and Fusion with CT for Stereotactic Radiation Therapy Planning of Retinoblastoma
Pica A., Karahanoglu Fikret I., Ciurte A.R., Gorthi S., Balmer A., Munier F., Thiran J.P., Bach Cuadra M., 2011. dans ISRS 2011, 10th Biennial Congress and Exhibition of the International Stereotactic Radio Surgery Society.
[serval:BIB_46D8AD8EF602]
 
A Cell Permeable Rasgap-derived Peptide Sensitizes Cancer Cells To Radiotherapy
Viertl D., Annibaldi A., Oezsahin M., Mirimanoff R., Widmann C., Matzinger O., 2011. pp. S738 dans ASTRO 2011, 53rd Annual Meeting of the American Society for Radiation Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.
[DOI][WoS][serval:BIB_A7A569657C12]
Adjuvant or radical fractionated stereotactic radiotherapy for patients with pituitary functional and nonfunctional macroadenoma.
Weber D.C., Momjian S., Pralong F.P., Meyer P., Villemure J.G., Pica A., 2011. Radiation Oncology, 6 p. 169.
[URN][DOI][WoS][Pmid][serval:BIB_2498B617519F]
 
An Efficient Segmentation Method for Ultrasound Images based on a Semi-supervised Approach and Patch-based Features
Ciurte A.R., Houhou N., Nedevschi S., Pica A., Munier F., Thiran J.P., Bresson X., Bach Cuadra M., 2011. pp. 969-972 dans Proceedings of the 8th IEEE International Symposium on Biomedical Imaging: From Nano to Macro, ISBI 2011, Biomedical Imaging.
[DOI][serval:BIB_8C933F116BF4]
 
Carotid Dose Spring in Definitive Irradiation of T1N0 Squamous Cell Laryngeal Carcinoma Using Helical Tomotherapy
Cosinschi A., Khanfir K., Joosten A., Boujelbene N., Herrera F., Pachoud M., Matzinger O., Ozsahin M., 2011. pp. S518-S519 dans ASTRO 2011, 53rd Annual Meeting of the American Society for Radiation Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.
[DOI][WoS][serval:BIB_552A44D45017]
 
Carotid sparing in definitive irradiation of T1N0 squamous cell larnyx cancer using helical tomotherapy
Cosinschi A., Khanfir K., Joosten A., Bouchaab H., Herrara E., Pachoud M., Matzinger O., Mirimanoff R., Ozsahin M., 2011. p. 685 dans ICT 2011, International Conference on Tomotherapy, Strahlentherapie und Onkologie. Peer-reviewed.
[WoS][serval:BIB_A3BC9C15F329]
 
Carotid sparing in t1-t2 no glottic cancer using helical tomotherapy
Cosinschi A., Khanfir K., Boujelbene N., Herrera F., Pachoud M., Matzinger O., Ozsahin M., 2011. p. 536 dans 15th Annual Meeting of the Scientific Association of Swiss Radiation Oncology, Strahlentherapie und Onkologie. Peer-reviewed.
[WoS][serval:BIB_CD670E5ED273]
 
Combined radiohormonotherapy in node positive lymph node prostate cancer
Herrmann E., Boujelbene N., Ozsahin M., Khanfir K., Mirimanoff R.O., Jichlinski P., Gygi C., Zouhair A., 2011. p. 537 dans 15th Annual Meeting of the Scientific Association of Swiss Radiation Oncology, Strahlentherapie und Onkologie. Peer-reviewed.
[WoS][serval:BIB_57BCC6996D76]
 
Concurrent or Sequential Adjuvant Letrozole and Radiotherapy after Conservative Surgery for Early-stage Breast Cancer: Long-term Results of the Cohort Phase 2 Randomized Trial
Azria D., Lemanski C., Romieu G., Gutowski M., Gourgou S., Moscardo C.L., Fenoglietto P., Ozsahin M., 2011. pp. S34-S35 dans ASTRO 2011, 53rd Annual Meeting of the American Society for Radiation Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.
[DOI][WoS][serval:BIB_F449702771D6]
Early occurrence of lung adenocarcinoma and breast cancer after radiotherapy of a chest wall sarcoma in a patient with a de novo germline mutation in TP53.
Ferrarini A., Auteri-Kaczmarek A., Pica A., Boesch N., Heinimann K., Schäfer S.C., Vesnaver-Megalo S., Cina V., Beckmann J.S., Monnerat C., 2011. Familial Cancer, 10 (2) pp. 187-192.
[URN][DOI][WoS][Pmid][serval:BIB_28AEEE440C11]
 
Early stage primary bone lymphoma - a retrospective, multicenter rare cancer network (rcn) study
Cai L., Stauder M.C., Zhang Y.J., Poortmans P., Li Y.X., Constantinou N., Thariat J., Kadish S., Nguyen T.D., Kirova Y.M. et al., 2011. p. 538 dans 15th Annual Meeting of the Scientific Association of Swiss Radiation Oncology, Strahlentherapie und Onkologie. Peer-reviewed.
[WoS][serval:BIB_A6CAD49AEB93]
 
Estimation of Radiation Dose and Cancer Risk Following Diagnostic and Therapeutic Radiation Exposure in Stage I Seminoma Patients
Herrera F., Heym L., Le Coultre R., Joosten A., Verdun F., Moeckli R., Ozsahin M., Berthold D., 2011. dans SASRO 2011, Scientific Association of Swiss Radiation Oncology.
[serval:BIB_D04377227508]
 
European French-speaking study from the GEMO group on bone metastases management: a special focus on external beam radiotherapy practice survey.
Magné N., Chargari C., Mirimanoff R.O., Olivier P., Vuillez J.P., Tubiana-Hulin M., Body J.J., Lagrange J.L., 2011. Supportive Care in Cancer, 19 (10) pp. 1565-1572.
[DOI][WoS][Pmid][serval:BIB_6DB2CB07EF9A]
 
Extrapleural Pneumonectomy With Venous Confluence Resection for Stage IVA Thymic Tumors.
Gonzalez M., Krueger T., Perentes J.Y., Matzinger O., Peters S., Ris H.B., 2011. Annals of Thoracic Surgery, 91 (3) pp. 941-943. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_496D6CFF13A0]
 
Gamma Knife, CyberKnife, TomoTherapy: gadgets or useful tools?
Levivier M., Gevaert T., Negretti L., 2011. Current Opinion in Neurology, 24 (6) pp. 616-625.
[DOI][WoS][Pmid][serval:BIB_2792C3DFEFE8]
 
Gefitinib in Combination With Irradiation With or Without Cisplatin in Patients With Inoperable Stage III Non-Small Cell Lung Cancer: A Phase I Trial.
Rothschild S., Bucher S.E., Bernier J., Aebersold D.M., Zouhair A., Ries G., Lombrieser N., Lippuner T., Lütolf U.M., Glanzmann C. et al., 2011. International Journal of Radiation Oncology, Biology, Physics, 80 (1) pp. 126-132.
[DOI][WoS][Pmid][serval:BIB_3E529A222A70]
 
Helical tomotherapy in the treatment of anal canal cancer: 3-year clinical experience
Bouchaab H., Matzinger O., Ugurluer G., Pachoud M., Vallet V., Mirimanoff R., Ozsahin M., 2011. p. 683 dans ICT 2011, International Conference on Tomotherapy, Strahlentherapie und onkologie. Peer-reviewed.
[WoS][serval:BIB_D15EB233648F]
 
Hippocampal sparing whole brain radiotherapy and simultaneously integrated boost with helical tomotherapy in patients with brain metastases
Coskun M., Negretti L., Herrmann E., Breunewal T., Mirimanoff R., Ozsahin M., 2011. p. 698 dans ICT 2011, International Conference on Tomotherapy, Strahlentherapie und Onkologie. Peer-reviewed.
[WoS][serval:BIB_3E1CFB709A94]
 
Hypofractionated radiotherapy in the treatment of diffuse intrinsic pontine glioma in children: a single institution's experience
Negretti L., Bouchireb K., Levy-Piedbois C., Habrand J.L., Dhermain F., Kalifa C., Grill J., Dufour C., 2011. p. 520 dans 15th Annual Meeting of the Scientific Association of Swiss Radiation Oncology, Strahlentherapie und Onkologie.
[WoS][serval:BIB_C47A81EE7155]
 
Induction treatment in sarcoma
Matter M., Gay B., Christinat A., Zouhair A., Leyvraz S., 2011. pp. 267-302 dans Aigner K.R., Stephens F.O. (eds.) Induction chemotherapy : integrated treatment programs for locally advanced cancers chap. 21, Springer.
[DOI][serval:BIB_128628C708B6]
 
Intensity modulated radiation therapy or stereotactic fractionated radiotherapy for infratentorial ependymoma in children: a multicentric study.
Weber D.C., Zilli T., Do H.P., Nouet P., Gumy Pause F., Pause F.G., Pica A., 2011. Journal of Neuro-oncology, 102 (2) pp. 295-300.
[DOI][WoS][Pmid][serval:BIB_84DBBE65BAFD]
 
Intérêt de la tomographie par émission de positons couplée à la scanographie (TEP/TDM) dans les cancers urologiques [Value of positron emission tomography and computer tomography (PET/CT) for urologic malignancies].
Boujelbene N., Prior J.O., Boubaker A., Azria D., Schaffer M., Gez E., Jichlinski P., Meuwly J.Y., Mirimanoff R.O., Ozsahin M. et al., 2011. Cancer Radiothérapie, 15 (4) pp. 307-315.
[DOI][WoS][Pmid][serval:BIB_4D5186A00AD2]
 
Intérêt des marqueurs sanguins dans la prédiction de la toxicité radio-induite [Interest of blood markers in predicting radiation-induced toxicity].
Lacombe J., Solassol J., Coelho M., Ozsahin M., Azria D., 2011. Cancer Radiothérapie, 15 (5) pp. 390-393.
[DOI][WoS][Pmid][serval:BIB_440096CFA594]
 
Low-dose radiotherapy in indolent lymphoma.
Rossier C., Schick U., Miralbell R., Mirimanoff R.O., Weber D.C., Ozsahin M., 2011. International Journal of Radiation Oncology, Biology, Physics, 81 (3) pp. e1-e6.
[DOI][WoS][Pmid][serval:BIB_F14CA043B977]
 
Mandibular osteoradionecrosis in squamous cell carcinoma of the oral cavity and oropharynx: incidence and risk factors.
Monnier Y., Broome M., Betz M., Bouferrache K., Ozsahin M., Jaques B., 2011. Otolaryngology head and Neck Surgery, 144 (5) pp. 726-32.
[DOI][WoS][Pmid][serval:BIB_39ACE12FBB5F]
 
Outcome and Prognostic Factors in Adenosquamous Carcinoma of the Head and Neck - a Multicenter Rare Cancer Network Study
Schick U., Betz M., Ghadjar P., Kaanders J.H.A.M., Demiroz C., Ozsahin M., 2011. pp. S555 dans European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, European Journal of Cancer. Peer-reviewed.
[WoS][serval:BIB_539C2EB80456]
 
Outcome and Prognostic Factors in Adenosquamous Carcinoma of the Head and Neck: A Multicenter Rare Cancer Network Study
Schick U., Betz M., Ghadjar P., Kaanders J.H.A.M., Ozsahin M., 2011. pp. S541-S542 dans ASTRO 2011, 53rd Annual Meeting of the American Society for Radiation Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.
[DOI][WoS][serval:BIB_9393D1BF0199]
 
Personalizing locoregional treatment in the adjuvant setting of early breast cancer on the basis of molecular background: an exciting enigma.
Tsoutsou P.G., Jeanneret Sozzi W., Matzinger O., Ozsahin M., 2011. Journal of Clinical Oncology, 29 (35) pp. 4721-2; author reply 4723-4. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_528D0EFF071B]
 
Primary testicular lymphoma: review
Boujelbene N., Ketterer N., Boujelbene N., Khanfir K., Bhagwati S., Herrmann E., Mirimanoff R. O., Ozsahin M., Zouhair A., 2011. Oncologie, 13 (9) pp. 598-604. Peer-reviewed.
[DOI][WoS][serval:BIB_3A98870D16D4]
 
Prise en charge des séminomes sécrétants de l'hormone chorionique gonadotrope [Management of chorionic gonadotropin-producing seminoma.]
Boujelbene N., Ozsahin M., Ugurluer G., Gaye M.P., Mirimanoff R.O., Zouhair A., 2011. Progrès en Urologie, 21 (5) pp. 308-313.
[DOI][WoS][Pmid][serval:BIB_7F2347D77CC1]
 
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.
Weller M., Gorlia T., Cairncross J.G., van den Bent M.J., Mason W., Belanger K., Brandes A.A., Bogdahn U., Macdonald D.R., Forsyth P. et al., 2011. Neurology, 77 (12) pp. 1156-64.
[DOI][WoS][Pmid][serval:BIB_46BE40E4C620]
 
Prostate cancer: F-18-fluorocholine PET-CT utility. [Cancer de la prostate : utilité de la TEP-TDM à la 18F-fluorocholine.]
Boubaker A., Houzard C., Zouhair A., Got P., Orcurto M.V., Giammarile F., 2011. Médecine Nucléaire, 35 (8) pp. 446-454. Peer-reviewed.
[DOI][WoS][serval:BIB_F25EE3596E91]
 
Pseudoprogression after high-dose busulfan-thiotepa with autologous stem cell transplantation and radiation therapy in children with brain tumor: impact on survival
Negretti L., Blanchard P., Couanet D., Benhamou E., Goma G., Habrand J.L., Dhermain F., Valteau-Couanet D., Grill J., Dufour C., 2011. p. 523 dans 15th Annual Meeting of the Scientific Association of Swiss Radiation Oncology, Strahlentherapie und Onkologie.
[WoS][serval:BIB_141051E68C25]
Pure seminoma: A review and update.
Boujelbene N., Cosinschi A., Boujelbene N., Khanfir K., Bhagwati S., Herrmann E., Mirimanoff R.O., Ozsahin M., Zouhair A., 2011. Radiation Oncology, 6 p. 90.
[URN][DOI][WoS][Pmid][serval:BIB_F4D093B682AF]
 
Quoi de neuf dans le traitement des séminomes  [What's new in the treatment of seminomas?]
Boujelbene N., Ozsahin M., Khanfir K., Azria D., Mirimanoff R.O., Zouhair A., 2011. Cancer Radiotherapie, 15 (3) pp. 208-220.
[DOI][WoS][Pmid][serval:BIB_94EE8B645D9C]
 
Secondary Cancer Risk for Stage I Seminoma Patients - a Comparison of Adjuvant Treatment Versus Surveillance
Berthold D., Heym L., Le Coultre R., Joosten A., Verdun F., Moeckli R., Ozsahin M., Herrera F., 2011. pp. S511 dans European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, European Journal of Cancer. Peer-reviewed.
[WoS][serval:BIB_B5325D985752]
Sequential or concomitant chemotherapy in limited stage small-cell lung cancer.
Khanfir K., Elhfidh M., Anchisi S., Matzinger O., Bieri S., Mirimanoff R.O., Ozsahin M., Zouhair A., 2011. Swiss Medical Weekly, 141 pp. w13205.
[URN][DOI][WoS][Pmid][serval:BIB_965E5B4C2B4A]
 
Surveillance active du cancer de la prostate [Active surveillance in prostate cancer].
Valerio M., Vaucher L., Cerantola Y., Berthold D., Herrera F.G, Jichlinski P., 2011. Revue Médicale Suisse, 7 (320) pp. 2388-2391. Peer-reviewed.
[Pmid][serval:BIB_03B22396178D]
 
TEP/TDM à la choline dans le cancer de la prostate. [PET-CT at choline in prostate cancer.]
Zouhair A., 2011. Médecine Nucléaire, 35 (8) p. 445. Peer-reviewed.
[DOI][WoS][serval:BIB_32D552670D2D]
 
The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer Network.
Ghadjar P., Kaanders J.H., Poortmans P., Zaucha R., Krengli M., Lagrange J.L., Özsoy O., Nguyen T.D., Miralbell R., Baize A. et al., 2011. International Journal of Radiation Oncology, Biology, Physics, 81 (4) pp. e583-e591.
[DOI][WoS][Pmid][serval:BIB_939C5BFD177C]
 
The role of the radiotherapy technologist in gamma knife radiosurgery within a multidisciplinary team: the Lausanne experience
Bourquard R., Rodrigues J., Pisaturo O., Negretti L., Tetrault M.H., Levivier M., 2011. p. 526 dans 15th Annual Meeting of the Scientific Association of Swiss Radiation Oncology, Strahlentherapie und Onkologie. Peer-reviewed.
[WoS][serval:BIB_ACEB82A02437]
Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study.
Onal C., Li Y.X., Miller R.C., Poortmans P., Constantinou N., Weber D.C., Atasoy B.M., Igdem S., Ozsahin M., Ozyar E., 2011. Annals of Oncology, 22 (1) pp. 156-164.
[URN][DOI][WoS][Pmid][serval:BIB_B64146B4B35F]
 
Variability of a peripheral dose among various linac geometries for second cancer risk assessment.
Joosten Andreas, Bochud François, Baechler Sébastien, Levi Fabio, Mirimanoff René-Olivier, Moeckli Raphael, 2011. Physics in Medicine and Biology, 56 (16) pp. 5131-5151. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_80990C48A812]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University